JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 32 No. 6 1177-1182
© 1991 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kudo, M.
Right arrow Articles by Stadalnik, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kudo, M.
Right arrow Articles by Stadalnik, R. C.

Validation of In Vivo Receptor Measurements Via In Vitro Radioassay: Technetium-99m-Galactosyl-Neoglycoalbumin as Prototype Model

Masatoshi Kudo, David R. Vera, Walter L. Trudeau and Robert C. Stadalnik

Departments of Radiology and Internal Medicine, University of California, Davis, Medical Center, Sacramento, California

Correspondence: For reprints contact: Robert C. Stadalnik, MD, Division of Nuclear Medicine, University of California, Davis, Medical Center, 2315 Stockton Blvd., Sacramento, CA 95817.

ABSTRACT

Hepatic binding protein (HBP) is a hepatocyte-specific recaptor for serum asialoglycoproteins. The receptor also recognizes a synthetic glycoprotein that has been developed as a radiopharmaceutical, technetium-99m-galactosyl-neoglycoalbumin (99mTc-NGA). This report describes the correlation between receptor parameters measured in vivo via kinetic modeling of 99mTc-NGA and those measured by in vitro radioassay of biopsied liver tissue. Eleven patients with diffuse hepatic disease underwent percutaneous liver biopsy followed by a 99mTc-NGA functional imaging study. In vivo measurements of HBP quantity Ro and forward binding rate constant kb obtained from the kinetic analysis of 99mTc-NGA liver and blood time-activity data were compared to total receptor quantity and the HBP-99mTc-NGA association constant KA as measured by Scatchard binding assay of the biopsied tissue. The correlation coefficients between in vivo and in vitro measurements were 0.73 (df=8, p=0.015) and 0.98 (df=8, p< 0.01) for Ro and kb, respectively. The in vivo measurements of HBP biochemistry via kinetic analysis of the radiopharmaceutical time-activity data reflect the average concentration and affinity of the receptor. This study further substantiates the validity of 99mTc-NGA as a quantitative probe for the HBP receptor.




This article has been cited by other articles:


Home page
JNMHome page
N. Shuke, A. Okizaki, S. Kino, J. Sato, Y. Ishikawa, C. Zhao, S. Kinuya, N. Watanabe, K. Yokoyama, and T. Aburano
Functional Mapping of Regional Liver Asialoglycoprotein Receptor Amount from Single Blood Sample and SPECT
J. Nucl. Med., March 1, 2003; 44(3): 475 - 482.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
S. D. Colquhoun, C. A. Connelly, and D. R. Vera
Portal-Systemic Shunts Reduce Asialoglycoprotein Receptor Density in Rats
J. Nucl. Med., January 1, 2001; 42(1): 110 - 116.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1991 by the Society of Nuclear Medicine.